Bruce Alan Brown

1.1k total citations
69 papers, 558 citations indexed

About

Bruce Alan Brown is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Bruce Alan Brown has authored 69 papers receiving a total of 558 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 13 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Genetics. Recurrent topics in Bruce Alan Brown's work include Prostate Cancer Treatment and Research (29 papers), Hormonal and reproductive studies (13 papers) and Estrogen and related hormone effects (13 papers). Bruce Alan Brown is often cited by papers focused on Prostate Cancer Treatment and Research (29 papers), Hormonal and reproductive studies (13 papers) and Estrogen and related hormone effects (13 papers). Bruce Alan Brown collaborates with scholars based in United States, Canada and Belgium. Bruce Alan Brown's co-authors include Henry F. Edelhauser, Scott M. Mac Rae, Edwin L. Cooper, Edward J. Moticka, Jeffrey L. Marx, Allen B. Thach, Thomas P. Ward, J Dick, Robin Howard and George E. Sarris and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Contemporary Sociology A Journal of Reviews.

In The Last Decade

Bruce Alan Brown

53 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce Alan Brown United States 12 148 115 107 87 60 69 558
Yongming Zhang China 12 123 0.8× 148 1.3× 49 0.5× 55 0.6× 129 2.1× 54 570
Kaushik Sen India 12 31 0.2× 71 0.6× 100 0.9× 50 0.6× 75 1.3× 32 452
Michael Marrone United States 10 73 0.5× 229 2.0× 168 1.6× 71 0.8× 68 1.1× 20 703
S. Ramalingam India 9 74 0.5× 44 0.4× 70 0.7× 28 0.3× 124 2.1× 31 405
Nina Hautala Finland 19 43 0.3× 187 1.6× 273 2.6× 123 1.4× 296 4.9× 54 1000
R. Hofmann Germany 13 42 0.3× 40 0.3× 43 0.4× 69 0.8× 47 0.8× 59 450
Michèle M. Sale United States 13 36 0.2× 51 0.4× 57 0.5× 39 0.4× 256 4.3× 19 704
C. J. Chen Taiwan 13 106 0.7× 581 5.1× 475 4.4× 182 2.1× 103 1.7× 18 1.3k
Jindra Vrzalová Czechia 14 71 0.5× 32 0.3× 35 0.3× 49 0.6× 124 2.1× 33 471
Lijuan Fan China 14 199 1.3× 61 0.5× 43 0.4× 61 0.7× 150 2.5× 49 549

Countries citing papers authored by Bruce Alan Brown

Since Specialization
Citations

This map shows the geographic impact of Bruce Alan Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce Alan Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce Alan Brown more than expected).

Fields of papers citing papers by Bruce Alan Brown

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce Alan Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce Alan Brown. The network helps show where Bruce Alan Brown may publish in the future.

Co-authorship network of co-authors of Bruce Alan Brown

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce Alan Brown. A scholar is included among the top collaborators of Bruce Alan Brown based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce Alan Brown. Bruce Alan Brown is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spratt, Daniel E., Daniel J. George, Neal D. Shore, et al.. (2024). Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer. JAMA Oncology. 10(5). 594–594. 4 indexed citations
2.
Ross, Ashley E., Stacie Hudgens, Bruce Alan Brown, et al.. (2024). Development of a Novel Patient-Reported Outcome Measure to Assess Symptoms and Impacts of Androgen Deprivation Therapy for Advanced Prostate Cancer. Advances in Therapy. 41(8). 3076–3088.
3.
Tutrone, Ronald, Fred Saad, Daniel J. George, et al.. (2023). Testosterone Recovery for Relugolix Versus Leuprolide in Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study. European Urology Oncology. 7(4). 906–913. 6 indexed citations
4.
Rini, Brian I., Jun Zhang, O. Hall, et al.. (2023). 1910P Evaluation of a genome-wide methylome enrichment platform for circulating tumor DNA quantification and prognostic performance in renal cell carcinoma (RCC). Annals of Oncology. 34. S1028–S1028. 1 indexed citations
5.
George, Daniel J., Fred Saad, Michael S. Cookson, et al.. (2023). Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate Cancer. Clinical Genitourinary Cancer. 21(3). 383–392.e2. 6 indexed citations
6.
Dunshee, Curtis, Paul Sieber, Laurence Belkoff, et al.. (2023). A Phase I Clinical Trial Evaluating the Safety and Dosing of Relugolix with Novel Hormonal Therapy for the Treatment of Advanced Prostate Cancer. Targeted Oncology. 18(3). 383–390. 7 indexed citations
7.
Shore, Neal D., Bryan A. Mehlhaff, Michael S. Cookson, et al.. (2023). Impact of Concomitant Cardiovascular Therapies on Efficacy and Safety of Relugolix vs Leuprolide: Subgroup Analysis from HERO Study in Advanced Prostate Cancer. Advances in Therapy. 40(11). 4919–4927. 4 indexed citations
8.
Tombal, Bertrand, Sean P. Collins, Alicia K. Morgans, et al.. (2023). Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study. European Urology. 84(6). 579–587. 8 indexed citations
9.
Tutrone, Ronald, Fred Saad, Daniel J. George, et al.. (2022). Testosterone recovery for relugolix versus leuprolide in men with advanced prostate cancer: Results from the phase 3 HERO study.. Journal of Clinical Oncology. 40(6_suppl). 104–104. 2 indexed citations
10.
11.
Schultz, Neil M., Neal D. Shore, Simon Chowdhury, et al.. (2018). Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials. BMC Urology. 18(1). 77–77. 1 indexed citations
12.
Brown, Bruce Alan, et al.. (2005). The grotesque dancer on the eighteenth-century stage : Gennaro Magri and his world. University of Wisconsin Press eBooks. 7 indexed citations
13.
14.
Brown, Bruce Alan, et al.. (2001). MRI Artifact Masquerading as Orbital Disease. International Ophthalmology. 24(6). 343–347. 7 indexed citations
15.
Brown, Bruce Alan, Christopher Parker, & Kraig S. Bower. (2001). Effective Steroid-sparing Treatment for Peripheral Ulcerative Keratitis and Pyoderma Gangrenosum. Cornea. 20(1). 117–118. 17 indexed citations
16.
Brown, Bruce Alan, et al.. (1998). Retinopathy of prematurity: evaluation of risk factors. International Ophthalmology. 22(5). 279–283. 27 indexed citations
17.
Brown, Bruce Alan. (1995). W. A. Mozart: Così fan tutte. Medical Entomology and Zoology. 2 indexed citations
18.
Cahill, Peter D., Bruce Alan Brown, Cynthia E. Handen, et al.. (1987). Incomplete biochemical adaptation of vein grafts to the arterial environment in terms of prostacyclin production. Journal of Vascular Surgery. 6(5). 496–503. 2 indexed citations
19.
Brown, Bruce Alan. (1986). Christoph Willibald Gluck and opera-comique in Vienna, 1754-1764. University Microfilms International eBooks. 1 indexed citations
20.
Brown, Bruce Alan & Edwin L. Cooper. (1976). Immunological dichotomy in the larval bullfrog spleen.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 30(2). 299–305. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yongming Zhang Breakdown of academic impact, for papers by Kaushik Sen Breakdown of academic impact, for papers by Michael Marrone Breakdown of academic impact, for papers by S. Ramalingam Breakdown of academic impact, for papers by Nina Hautala Breakdown of academic impact, for papers by R. Hofmann Breakdown of academic impact, for papers by Michèle M. Sale Breakdown of academic impact, for papers by C. J. Chen Breakdown of academic impact, for papers by Jindra Vrzalová Breakdown of academic impact, for papers by Lijuan Fan
Rankless by CCL
2026